CITADEL ADVISORS LLC - 14 Feb 2025 SCHEDULE 13G Report for Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 per share (the "Shares") (AARD)

Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Security
Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 per share (the "Shares")
Symbol
AARD
Shares outstanding
21,303,054 shares
Disclosed Ownership
1,192,971 shares
Ownership
5.6%
Form type
SCHEDULE 13G
Filing time
24 Feb 2025, 17:55:38 UTC
Date of event
14 Feb 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 5.4% 1,152,375 0 1,152,375 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 5.4% 1,152,375 0 1,152,375 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 5.4% 1,152,375 0 1,152,375 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0.2% 40,596 0 40,596 /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities Group LP 0.2% 40,596 0 40,596 /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities GP LLC 0.2% 40,596 0 40,596 /s/ Guy Miller Guy Miller, Authorized Signatory
Kenneth Griffin 5.6% 1,192,971 0 1,192,971 /s/ Seth Levy Seth Levy, attorney-in-fact*